BMS-927711 (Rimegepant): Mechanism of Action

BMS-927711 (Rimegepant) MOA:Targeting CGRP Receptor/cAMP Signaling Pathway for Migraine

🎯 check BMS-927711 (Rimegepant) product page

BMS-927711 is a potent CGRP receptor antagonist. It affects cAMP signaling by blocking CGRP, to inhibit vasorelaxation.

Primary Applications and Mechanism of Action